Signaling cross talk between TGF-β/Smad and other signaling pathways

Cold Spring Harbor Perspectives in Biology

Volumn 9, Issue 1, 2017, Pages

  Luo, Kunxin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIPPO PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANIMAL; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; HEDGEHOG PROTEINS; HUMANS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 85009113582     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a022137     Document Type: Review

References (216)

1. Adhikari A, Xu M, Chen ZJ. 2007. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226.
2. Alarcón C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al. 2009. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139: 757-769.
3. Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. 2011. A Smad action turnover switch operated by WWdomain readers of a phosphoserine code. Genes Dev 25: 1275-1288.
4. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. A mechanical checkpoint controls multicellular growth through YAP/ TAZ regulation by actin-processing factors. Cell 154: 1047-1059.
5. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, et al. 2003. Transient activation of NF-κB through a TAK1/ IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: Implications in liver tumor formation. Oncogene 22: 412-425.
6. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. 2004. Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol 172: 7123-7135.
7. Attisano L, Labbé E. 2004. TGF-β and Wnt pathway crosstalk. Cancer Metastasis Rev 23: 53-61.
8. Attisano L, Wrana JL. 2000. Smads as transcriptional comodulators. Curr Opin Cell Biol 12: 235-243.
9. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810.
10. Beyer TA, Weiss A, Khomchuk Y, Huang K, Ogunjimi AA, Varelas X, Wrana JL. 2013. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 5: 1611-1624.
11. Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S. 2008. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS ONE 3: e2863.
12. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Böttinger EP. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 14: 187-197.
13. Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, Lendahl U, Ibanez CF. 2003. Cross-talk between the Notch and TGF-β signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 163: 723-728.
14. Bozulic L, Hemmings BA. 2009. PIKKing on PKB: Regulation of PKB activity by phosphorylation. Curr Opin Cell Biol 21: 256-261.
15. Brandl M, Seidler B, Haller F, Adamski J, Schmid RM, Saur D, Schneider G. 2010. IKKα controls canonical TGF-β-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J Cell Sci 123: 4231-4239.
16. Bright JJ, Sriram S. 1998. TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 161: 1772-1777.
17. Brodin G, Ahgren A, ten Dijke P, Heldin CH, Heuchel R. 2000. Efficient TGF-β induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem 275: 29023-29030.
18. Burdon T, Stracey C, Chambers I, Nichols J, Smith A. 1999. Suppression of SHP-2 and ERK signalling promotes selfrenewal of mouse embryonic stem cells. Dev Biol 210: 30-43.
19. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383: 443-446.
20. Carlson ME, Hsu M, Conboy IM. 2008. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454: 528-532.
21. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106-1117.
22. Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ. 2008. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J Biol Chem 283: 1293-1307.
23. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 22: 746-755.
24. Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. 2004. Akt interacts directlywith Smad3 to regulate the sensitivity to TGF-β-induced apoptosis. Nat Cell Biol 6: 366-372.
25. Crease DJ, Dyson S, Gurdon JB. 1998. Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci 95: 4398-4403.
26. Cui Y, Tian Q, Christian JL. 1996. Synergistic effects of Vg1 and Wnt signals in the specification of dorsal mesoderm and endoderm. Dev Biol 180: 22-34.
27. Cullingworth J, Hooper ML, Harrison DJ, Mason JO, Sirard C, Patek CE, Clarke AR. 2002. Carcinogen-induced pan-creatic lesions in the mouse: Effect of Smad4 and Apc genotypes. Oncogene 21: 4696-4701.
28. Dahle O, Kumar A, Kuehn MR. 2010. Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal 3: ra48.
29. Dahlqvist C, Blokzijl A, Chapman G, Falk A, Dannaeus K, Ibanez CF, Lendahl U. 2003. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 130: 6089-6099.
30. de Jong DS, Steegenga WT, Hendriks JM, van Zoelen EJ, Olijve W, Dechering KJ. 2004. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem Biophys Res Commun 320: 100-107.
31. Dennler S, André J, Alexaki I, Li A, Magnaldo T, ten Dijke P, Wang XJ, Verrecchia F, Mauviel A. 2007. Induction of sonic hedgehog mediators by transforming growth factor-β: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res 67: 6981-6986.
32. Dennler S, André J, Verrecchia F, Mauviel A. 2009. Cloning of the human GLI2 promoter: Transcriptional activation by transforming growth factor-β via SMAD3/β-catenin cooperation. J Biol Chem 284: 31523-31531.
33. Descargues P, Sil AK, Sano Y, Korchynskyi O, Han G, Owens P, Wang XJ, Karin M. 2008. IKKα is a critical coregulator of a Smad4-independent TGF-β-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci 105: 2487-2492.
34. Dey N, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. 2012. TGF-β-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PLoS ONE 7: e42316.
35. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. 2007. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
36. Dowdy SC, Mariani A, Janknecht R. 2003. HER2/Neu-and TAK1-mediated up-regulation of the transforming growth factor β inhibitor Smad7 via the ETS protein ER81. J Biol Chem 278: 44377-44384.
37. Downward J. 2004. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177-182.
38. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
39. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M. 2003. Transforming growth factor-b1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14: 529-544.
40. Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, Lyons KM, Pangas SA, Matzuk MM. 2010. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol 24: 1251-1266.
41. Eivers E, Fuentealba LC, Sander V, Clemens JC, Hartnett L, De Robertis EM. 2009. Mad is required for wingless signaling in wing development and segment patterning in Drosophila. PLoS ONE 4: e6543.
42. Eivers E, Demagny H, Choi RH, De Robertis EM. 2011. Phosphorylation of Mad controls competition between wingless and BMP signaling. Sci Signal 4: ra68.
43. Ekman M, Mu Y, Lee SY, Edlund S, Kozakai T, Thakur N, Tran H, Qian J, Groeden J, Heldin CH, et al. 2012. APC and Smad7 link TGF-β type I receptors to the microtubule system to promote cell migration. Mol Biol Cell 23: 2109-2121.
44. Estaras C, Benner C, Jones KA. 2015. SMADs and YAP compete to control elongation of β-catenin: LEF-1-recruited RNAPII during hESC differentiation. Mol Cell 58: 780-793.
45. Fei C, Li Z, Li C, Chen Y, Chen Z, He X, Mao L, Wang X, Zeng R, Li L. 2013. Smurf1-mediated Lys29-linked nonproteolytic polyubiquitination of axin negatively regulates Wnt/β-catenin signaling. Mol Cell Biol 33: 4095-4105.
46. Feng XH, Derynck R. 2005. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693.
47. Ferrigno O, Lallemand F, Verrecchia F, L’Hoste S, Camonis J, Atfi A, Mauviel A. 2002. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene 21: 4879-4884.
48. Freudlsperger C, Bian Y, ContagWise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C. 2013. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene 32: 1549-1559.
49. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/ Smad1 signal. Cell 131: 980-993.
50. Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, et al. 2012. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 209: 479-494.
51. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in antiapoptosis. Immunity 5: 449-460.
52. Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. 2001. Axin facilitates Smad3 activation in the transforming growth factor b signaling pathway. Mol Cell Biol 21: 5132-5141.
53. Galliher AJ, Schiemann WP. 2007. Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752-3758.
54. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. 2002. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277: 33361-3368.
55. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. 2008. TGF-β coordinately activates TAK1/MEK/AKT/NFκB and SMAD pathways to promote osteoclast survival. Exp Cell Res 314: 2725-2738.
56. Gudey SK, Sundar R, Mu Y, Wallenius A, Zang G, Bergh A, Heldin CH, Landström M. 2014. TRAF6 stimulates the tumor-promoting effects of TGF-β type I receptor through polyubiquitination and activation of presenilin 1. Sci Signal 7: ra2.
57. Guo X, Wang XF. 2009. Signaling cross-talk between TGF-β/ BMP and other pathways. Cell Res 19: 71-88.
58. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. 2008. Axin and GSK3-control Smad3 protein stability and modulate TGF-β signaling. Genes Dev 22: 106-120.
59. Hamamoto T, Beppu H, Okada H, Kawabata M, Kitamura T, Miyazono K, Kato M. 2002. Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Cancer Res 62: 5955-5961.
60. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. 2008. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496-5509.
61. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, et al. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet 36: 1117-1121.
62. Heldin CH, Moustakas A. 2011. Role of Smads in TGF-β signaling. Cell Tissue Res 347: 21-36.
63. Heldin CH, Landstrom M, Moustakas A. 2009. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21: 166-176.
64. Hinz M, Scheidereit C. 2013. The IκB kinase complex in NF-κB regulation and beyond. EMBO Rep 15: 46-61.
65. Hogan KA, Ravindran A, Podolsky MA, Glick AB. 2013. The TGF-β1 pathway is required for NFκB-dependent gene expression in mouse keratinocytes. Cytokine 64: 652-659.
66. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, et al. 2011. Noncanonical TGF-β signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332: 358-361.
67. Hoppler S, Moon RT. 1998. BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev 71: 119-129.
68. Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, Cui Z, Thannickal VJ. 2004. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p 38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279: 1359-1367.
69. Hudson C, Yasuo H. 2006. A signalling relay involving Nodal and Delta ligands acts during secondary notochord induction in Ciona embryos. Development 133: 2855-2864.
70. Hudson C, Lotito S, Yasuo H. 2007. Sequential and combinatorial inputs from Nodal, Delta2/Notch and FGF/ MEK/ERK signalling pathways establish a grid-like organisation of distinct cell identities in the ascidian neural plate. Development 134: 3527-3537.
71. Hui CC, Angers S. 2011. Gli proteins in development and disease. Annu Rev Cell Dev Biol 27: 513-537.
72. Hussein SM, Duff EK, Sirard C. 2003. Smad4 and b-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278: 48805-48814.
73. Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271: 28745-28748.
74. Ishinaga H, Jono H, Lim JH, Kweon SM, Xu H, Ha UH, Koga T, Yan C, Feng XH, Chen LF, et al. 2007. TGF-β induces p65 acetylation to enhance bacteria-induced NF-kB activation. EMBO J 26: 1150-1162.
75. Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, ten Dijke P. 2004. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J 23: 541-551.
76. Jahchan NS, Wang D, Bissell MJ, Luo K. 2012. SnoN regulates mammary gland alveologenesis and onset of lactation by promoting prolactin/Stat5 signaling. Development 139: 3147-3156.
77. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A. 2011. TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71: 5606-5610.
78. Javelaud D, Pierrat MJ, Mauviel A. 2012. Crosstalk between TGF-β and hedgehog signaling in cancer. FEBS Lett 586: 2016-2025.
79. Jeong HW, Kim IS. 2004. TGF-β1 enhances big-h3-mediated keratinocyte cell migration through the a3b1 integrin and PI3K. J Cell Biochem 92: 770-780.
80. Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. 2006. Smad3-dependent nuclear translocation of b-catenin is required for TGF-β1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev 20: 666-674.
81. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS, Kang SS. 2006. BMP-2-enhanced chondrogenesis involves p38 MAPKmediated down-regulation of Wnt-7a pathway. Mol Cells 22: 353-359.
82. Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. 2011. TGF-β promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res 71: 822-831.
83. Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al. 2013. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun 4: 2562.
84. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, et al. 2009. TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889.
85. Kim S, Jho EH. 2010. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem 285: 36420-36426.
86. Kim SW, Yoon SJ, Chuong E, Oyolu C, Wills AE, Gupta R, Baker J. 2011. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev Biol 357: 492-504.
87. Kim HJ, Kim JG, Moon MY, Park SH, Park JB. 2014. IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/ NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1. J Biol Chem 289: 1429-1440.
88. Kimelman D, Griffin KJ. 2000. Vertebrate mesendoderm induction and patterning. Curr Opin Genet Dev 10: 350-356.
89. Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR, Sugimoto K, Miyazono K. 2009. Autophagy is activated by TGF-β and potentiates TGF-β-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 69: 8844-8852.
90. Kleber M, Lee HY, Wurdak H, Buchstaller J, Riccomagno MM, Ittner LM, Suter U, Epstein DJ, Sommer L. 2005. Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol 169: 309-320.
91. Kon A, Vindevoghel L, Kouba DJ, Fujimura Y, Uitto J, Mauviel A. 1999. Cooperation between SMAD and NF-kB in growth factor regulated type VII collagen gene expression. Oncogene 18: 1837-1844.
92. Krausova M, Korinek V. 2014. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26: 570-579.
93. Kretzschmar M, Doody J, Massagué J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389: 618-622.
94. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. 2007. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134: 2895-2902.
95. Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM. 2005. Default neural induction: Neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev 19: 1022-1027.
96. Labbé E, Letamendia A, Attisano L. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci 97: 8358-8363.
97. Lamouille S, Derynck R. 2007. Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178: 437-451.
98. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. 2012. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125: 1259-1273.
99. Landström M. 2010. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 42: 585-589.
100. Larrivée B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A. 2012. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 22: 489-500.
101. Lawler S, Feng XH, Chen RH, Maruoka EM, Turck CW, Griswold-Prenner I, Derynck R. 1997. The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 272: 14850-14859.
102. Lechuga CG, Hernandez-Nazara ZH, Dominguez Rosales JA, Morris ER, Rincon AR, Rivas-Estilla AM, Esteban-Gamboa A, Rojkind M. 2004. TGF-β1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6K. Am J Physiol Gastrointest Liver Physiol 287: G974-G987.
103. Lee YI, Kwon YJ, Joo CK. 2004. Integrin-linked kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun 316: 997-1001.
104. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
105. Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC. 2004. The murine gastrin promoter is synergistically activated by transforming growth factor-β/Smad and Wnt signaling pathways. J Biol Chem 279: 42492-42502.
106. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL. 2008. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436.
107. Lengerke C, Schmitt S, Bowman TV, Jang IH, Maouche-Chrétien L, McKinney-Freeman S, Davidson AJ, Hammerschmidt M, Rentzsch F, Green JB, et al. 2008. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell 2: 72-82.
108. Li WX. 2008. Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 18: 545-551.
109. Li Z, Fei T, Zhang J, Zhu G, Wang L, Lu D, Chi X, Teng Y, Hou N, Yang X, et al. 2012. BMP4 Signaling Acts via dualspecificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell 10: 171-182.
110. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, et al. 2010. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118.
111. Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, Liu X, Feng XH, Lin X. 2004. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol 24: 7524-7537.
112. Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang XF. 1999. Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci 96: 4844-4849.
113. Lim JH, Jono H, Komatsu K, Woo CH, Lee J, Miyata M, Matsuno T, Xu X, Huang Y, Zhang W, et al. 2012. CYLD negatively regulates transforming growth factor-b-signalling via deubiquitinating Akt. Nat Commun 3: 771.
114. Liu C, Xu P, Lamouille S, Xu J, Derynck R. 2009. TACEmediated ectodomain shedding of the type I TGF-β receptor downregulates TGF-β signaling. Mol Cell 35: 26-36.
115. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, Chan SW, Lim CJ, Hong W, et al. 2010. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFβ-TrCP E3 ligase. J Biol Chem 285: 37159-37169.
116. Liu Y, Liu H, Meyer C, Li J, Nadalin S, Konigsrainer A, Weng H, Dooley S, ten Dijke P. 2013. Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J Biol Chem 288: 30708-30719.
117. Loose M, Patient R. 2004. A genetic regulatory network for Xenopus mesendoderm formation. Dev Biol 271: 467-478.
118. Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F. 2000. Interaction and functional cooperation of NF-κB with Smads. Transcriptional regulation of the JunB promoter. J Biol Chem 275: 28937-28946.
119. Mandal CC, Ghosh Choudhury G, Ghosh-Choudhury N. 2009. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with Smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology 150: 4989-4998.
120. Mao R, Fan Y, Mou Y, Zhang H, Fu S, Yang J. 2011. TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation. Cell Signal 23: 222-227.
121. Massagué J. 2012. TGF-β signalling in context. Nat Rev Mol Cell Biol 13: 616-630.
122. Masuda S, Kumano K, Shimizu K, Imai Y, Kurokawa M, Ogawa S, Miyagishi M, Taira K, Hirai H, Chiba S. 2005. Notch1 oncoprotein antagonizes TGF-β/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci 96: 274-282.
123. Matsuura I, Wang G, He D, Liu F. 2005. Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry 44: 12546-12553.
124. Maurya AK, Tan H, Souren M, Wang X, Wittbrodt J, Ingham PW. 2011. Integration of Hedgehog and BMP signalling by the engrailed2a gene in the zebrafish myotome. Development 138: 755-765.
125. Millet C, Yamashita M, Heller M, Yu LR, Veenstra TD, Zhang YE. 2009. A negative feedback control of transforming growth factor-β signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem 284: 19808-19816.
126. Mohammad KS, Javelaud D, Fournier PG, Niewolna M, McKenna CR, Peng XH, Duong V, Dunn LK, Mauviel A, Guise TA. 2011. TGF-β-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 71: 175-184.
127. Monteleone G, Mann J, Monteleone I, Vavassori P, Bremner R, Fantini M, Del Vecchio Blanco G, Tersigni R, Alessandroni L, Mann D, et al. 2004. A failure of transforming growth factor-β1 negative regulation maintains sustained NF-kB activation in gut inflammation. J Biol Chem 279: 3925-3932.
128. Mu Y, Gudey SK, Landström M. 2012. Non-Smad signaling pathways. Cell Tissue Res 347: 11-20.
129. Mullen AC, Orlando DA, Newman JJ, Loven J, Kumar RM, Bilodeau S, Reddy J, Guenther MG, DeKoter RP, Young RA. 2011. Master transcription factors determine celltype-specific responses to TGF-β signaling. Cell 147: 565-576.
130. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T. 1999. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284: 479-482.
131. Nallet-Staub F, Yin X, Gilbert C, Marsaud V, Ben Mimoun S, Javelaud D, Leof EB, Mauviel A. 2015. Cell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activation. Dev Cell 32: 640-651.
132. Niimi H, Pardali K, Heldin CH, Moustakas A. 2007. Notch signaling is necessary for epithelial growth arrest by TGF-β. J Cell Biol 176: 695-707.
133. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann’s organizer. Nature 403: 781-785.
134. Nobta M, Tsukazaki T, Shibata Y, Xin C, Moriishi T, Sakano S, Shindo H, Yamaguchi A. 2005. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem 280: 15842-15848.
135. Nostro MC, Cheng X, Keller GM, Gadue P. 2008. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2: 60-71.
136. Nowell C, Radtke F. 2013. Cutaneous Notch signaling in health and disease. Cold Spring Harb Perspect Med 3: a017772.
137. Nusse R. 2012. Wnt signaling. Cold Spring Harb Perspect Biol 4: a011163.
138. Nye MD, Almada LL, Fernandez-Barrena MG, Marks DL, Elsawa SF, Vrabel A, Tolosa EJ, Ellenrieder V, Fernandez-Zapico ME. 2014. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor b-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner. J Biol Chem 289: 15495-15506.
139. Ogawa K, Chen F, Kuang C, Chen Y. 2004. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a nuclear factor-κB site. Biochem J 381: 413-422.
140. Oh H, Irvine KD. 2011. Cooperative regulation of growth by Yorkie and Mad through Bantam. Dev Cell 20: 109-22.
141. Oka T, Mazack V, Sudol M. 2008. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283: 27534-27546.
142. Ota M, Sasaki H. 2008.Mammalian TEAD proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059-4069.
143. Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G, Chouaib S. 1999. Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-b: Relationship with IL-12 signaling. Blood 93: 1448-1455.
144. Park HW, Guan KL. 2013. Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol Sci 34: 581-589.
145. Perrot CY, Javelaud D, Mauviel A. 2013. Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment. Pharmacol Ther 137: 183-199.
146. Piccolo S, Dupont S, Cordenonsi M. 2014. The biology of YAP/TAZ: Hippo signaling and beyond. Physiol Rev 94: 1287-1312.
147. Quijano JC, Stinchfield MJ, Zerlanko B, Gibbens YY, Takaesu NT, Hyman-Walsh C, Wotton D, Newfeld SJ. 2010. The Sno oncogene antagonizes Wingless signaling during wing development in Drosophila. PLoS ONE 5: e11619.
148. Quijano JC, Stinchfield MJ, Newfeld SJ. 2011. Wg signaling via Zw3 and Mad restricts self-renewal of sensory organ precursor cells in Drosophila. Genetics 189: 809-824.
149. Rao P, Kadesch T. 2003. The intracellular form of Notch blocks transforming growth factor β-mediated growth arrest in Mv1Lu epithelial cells. Mol Cell Biol 23: 6694-6701.
150. Rashidian J, Le Scolan E, Ji X, Zhu Q, Mulvihill MM, Nomura D, Luo K. 2015. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Sci Signal 8: ra14.
151. Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC. 1995. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 270: 25715-25721.
152. Remy I, Montmarquette A, Michnick SW. 2004. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6: 358-365.
153. Rios I, Alvarez-Rodriguez R, Marti E, Pons S. 2004. BMP2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 131: 3159-3168.
154. Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. 2000. Structure, function, and biology of SHIP proteins. Genes Dev 14: 505-520.
155. Ross KR, Corey DA, Dunn JM, Kelley TJ. 2007. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal 19: 923-931.
156. Runyan CE, Schnaper HW, Poncelet AC. 2004. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-b1. J Biol Chem 279: 2632-2639.
157. Saha D, Datta PK, Beauchamp RD. 2001. Oncogenic ras represses transforming growth factor-β/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem 276: 29531-29537.
158. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague ´ J. 2007. Balancing BMPsignaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441-454.
159. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, et al. 2011. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940.
160. Schohl A, Fagotto F. 2002. b-catenin, MAPK and Smad signaling during early Xenopus development. Development 129: 37-52.
161. Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223.
162. Shimmi O, Newfeld SJ. 2013.New insights into extracellular and post-translational regulation of TGF-β family signalling pathways. J Biochem 154: 11-9.
163. Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, Menendez L, Kulik M, Dalton S. 2012. Signaling network crosstalk in human pluripotent cells: A Smad2/ 3-regulated switch that controls the balance between selfrenewal and differentiation. Cell Stem Cell 10: 312-326.
164. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M. 2008. The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: 1199-1207.
165. Stavridis MP, Lunn JS, Collins BJ, Storey KG. 2007.Adiscrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development 134: 2889-2894.
166. Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. 2012. Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther 11: 1587-1597.
167. Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S, et al. 2005.Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-β signaling. Oncogene 24: 5365-5374.
168. Szeto DP, Kimelman D. 2004. Combinatorial gene regulation by BMP and Wnt in zebrafish posterior mesoderm formation. Development 131: 3751-3760.
169. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM.1998. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92: 645-656.
170. Takaku K, Wrana JL, Robertson EJ, Taketo MM. 2002. No effects of Smad2 (Madh2) null mutation on malignant progression of intestinal polyps in ApcD716 knockout mice. Cancer Res 62: 4558-4561.
171. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. 2002. Smad-dependent GADD45b expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J 21: 6473-6482.
172. Takizawa T, Ochiai W, Nakashima K, Taga T. 2003. Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res 31: 5723-5731.
173. Teo AK, Arnold SJ, Trotter MW, Brown S, Ang LT, Chng Z, Robertson EJ, Dunn NR, Vallier L. 2011. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev 25: 238-250.
174. Tezuka K, Yasuda M, Watanabe N, Morimura N, Kuroda K, Miyatani S, Hozumi N. 2002. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 17: 231-239.
175. Theil T, Aydin S, Koch S, Grotewold L, Ruther U. 2002. Wnt and BMP signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. Development 129: 3045-3054.
176. Trompouki E, Bowman TV, Lawton LN, Fan ZP, Wu DC, DiBiase A, Martin CS, Cech JN, Sessa AK, Leblanc JL, et al. 2011. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147: 577-589.
177. Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H. 2001. Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun 289: 376-381.
178. Ulloa L, Doody J, Massagué J. 1999. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/ STAT pathway. Nature 397: 710-713.
179. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10: 837-848.
180. Vinals F, Pouysségur J. 2001. Transforming growth factor b1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling. Mol Cell Biol 21: 7218-7230.
181. Waddell DS, Liberati NT, Guo X, Frederick JP, Wang XF. 2004. Casein kinase I1 plays a functional role in the transforming growth factor-β signaling pathway. J Biol Chem 279: 29236-29246.
182. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. 2001. TAK1 is a ubiquitin-dependent kinase of MKKand IKK. Nature 412: 346-351.
183. Wang G, Matsuura I, He D, Liu F. 2009a. Transforming growth factor-b-inducible phosphorylation of Smad3. J Biol Chem 284: 9663-9673.
184. Wang K, Degerny C, Xu M, Yang XJ. 2009b. YAP, TAZ, and Yorkie:Aconserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol 87: 77-91
185. Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, Lin X, Feng XH. 2015. STAT3 selectively interacts with Smad3 to antagonize TGF-β. Oncogene doi: 10.1038/onc.2015.446.
186. Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. 2005. Transforming growth factor-β activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65: 10431-10440.
187. Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM, Wang XF. 1999. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor b. Mol Cell Biol 19: 1821-1830.
188. Wu S, Liu Y, Zheng Y, Dong J, Pan D. 2008. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14: 388-398.
189. Xanthos JB, Kofron M, Tao Q, Schaible K, Wylie C, Heasman J. 2002. The roles of three signaling pathways in the formation and function of the Spemann organizer. Development 129: 4027-4043.
190. Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, Zeng W, Chen ZJ. 2009. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461: 114-119.
191. Xia H, Ooi LL, Hui KM. 2013. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 58: 629-641.
192. Xu X, Han J, Ito Y, Bringas P Jr, Deng C, Chai Y. 2008. Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-β/BMP signaling during tooth and palate development. Dev Cell 15: 322-329.
193. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2011.
194. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE. 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell 31: 918-924.
195. Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NFκB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75: 1292-1301.
196. Ying QL, Nichols J, Chambers I, Smith A. 2003. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
197. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol Cell Biol 17: 7019-7028.
198. Yoshida-Koide U, Matsuda T, Saikawa K, Nakanuma Y, Yokota T, Asashima M, Koide H. 2004. Involvement of Ras in extraembryonic endoderm differentiation of embryonic stem cells. Biochem Biophys Res Commun 313: 475-481.
199. Yu FX, Guan KL. 2013. The Hippo pathway: Regulators and regulations. Genes Dev 27: 355-371.
200. Yu P, Pan G, Yu J, Thomson JA. 2011. FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell 8: 326-334.
201. Zamurovic N, Cappellen D, Rohner D, Susa M. 2004. Coordinated activation of notch, Wnt, and transforming growth factor-β signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 279: 37704-37715.
202. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. 2004. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBOJ 23: 1155-1165.
203. Zhang Y, Feng XH, Derynck R. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394: 909-913.
204. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. 2008. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 14: 377-387.
205. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, Xiong Y, Lei QY, Guan KL. 2009. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 284: 13355-13362.
206. Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, et al. 2012. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol 14: 717-726.
207. Zhang L, Zhou F, Garcia de Vinuesa A, de Kruijf EM, Mesker WE, Hui L, Drabsch Y, Li Y, Bauer A, Rousseau A, et al. 2013. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol Cell 51: 559-572.
208. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
209. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, et al. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
210. Zhao B, Kim J, Ye X, Lai ZC, Guan KL. 2009. Both TEADbinding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 69: 1089-1098.
211. Zhou J, Jain S, Azad AK, Xu X, Yu HC, Xu Z, Godbout R, Fu Y. 2016.Notch and TGF-β form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells. Cell Signal 28: 838-849.
212. Zhu Y, Ahlemeyer B, Bauerbach E, Krieglstein J. 2001. TGF-β1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem Int 38: 227-235.
213. Zhu Y, Culmsee C, Klumpp S, Krieglstein J. 2004. Neuroprotection by transforming growth factor-b1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogenactivated protein kinase-extracellular-signal regulated kinase1, 2 signaling pathways. Neuroscience 123: 897-906.
214. Zhu Q, Le Scolan E, Jahchan N, Ji X, Xu A, Luo K. 2016. SnoN antagonizes the Hippo kinase complex to promote TAZ signaling during breast carcinogenesis. Dev Cell 37: 1-14.
215. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
216. Zorn AM, Butler K, Gurdon JB. 1999. Anterior endomesoderm specification in Xenopus by Wnt/β-catenin and TGF-β signalling pathways. Dev Biol 209: 282-297.